The investment team seeks to invest in companies within its preferred themes with sustainable growth characteristics at attractive valuations that do not reflect their long-term potential.
As of 31 December 2020 | QTD | YTD | 1 Yr | 3 Yr | 5 Yr | 10 Yr | Inception |
---|---|---|---|---|---|---|---|
Advisor Class: APDHX | 13.96 | 29.35 | 29.35 | 17.88 | 16.12 | 13.42 | 13.83 |
MSCI All Country World Index | 14.68 | 16.25 | 16.25 | 10.06 | 12.26 | 9.13 | 9.36 |
As of 31 December 2020 | QTD | YTD | 1 Yr | 3 Yr | 5 Yr | 10 Yr | Inception |
---|---|---|---|---|---|---|---|
Advisor Class: APDHX | 13.96 | 29.35 | 29.35 | 17.88 | 16.12 | 13.42 | 13.83 |
MSCI All Country World Index | 14.68 | 16.25 | 16.25 | 10.06 | 12.26 | 9.13 | 9.36 |
2016 | 2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|---|
Advisor Class: APDHX | -1.87 | 31.34 | -3.41 | 31.13 | 29.35 |
MSCI All Country World Index | 7.86 | 23.97 | -9.41 | 26.60 | 16.25 |
Gross | Net | |
Annual Report 30 September 2020 | 2.51% | 1.25% |
Prospectus 4 August 2020 | 1.20% | — |
Prospectus Figures: Includes estimated expenses for the current fiscal year. Reflects a reduction in management fees, effective as of 15 Nov 2019. Annual Report Figures: For the period from commencement of operations 5 Aug 2020 through 30 Sep 2020. Net expenses reflect a contractual expense limitation agreement in effect through 31 January 2022. See prospectus for further details.
Top 10 Holdings (% of total portfolio as of 31 December 2020) |
|
---|---|
Halozyme Therapeutics Inc (United States) | 3.8 |
Vertiv Holdings Co (United States) | 3.2 |
Amazon.com Inc (United States) | 3.0 |
Microsoft Corp (United States) | 2.9 |
Johnson Controls International PLC (United States) | 2.7 |
ACADIA Pharmaceuticals Inc (United States) | 2.5 |
Fidelity National Information Services Inc (United States) | 2.4 |
Jeol Ltd (Japan) | 2.4 |
Illumina Inc (United States) | 2.3 |
Carrier Global Corp (United States) | 2.2 |
Total | 27.5% |
Portfolio Statistics (as of 31 December 2020) |
|
---|---|
Median Market Cap (Billions) | $17.9 |
Weighted Avg. Market Cap (Billions) | $189.7 |
Weighted Harmonic Avg. P/E (FY1) | 30.3X |
Weighted Harmonic Avg. P/E (FY2) | 24.3X |
Weighted Avg. LT EPS Growth Rate (3-5 Yr) | 15.7% |
Weighted Avg. Operating Margin | 8.1% |
Active Share | 86.3% |
Portfolio Turnover Rate | 137.9% |
Number of Securities | 84 |
Number of Countries | 20 |
Cash (% of total portfolio) | 1.2% |
Region Allocation (% of total portfolio equities as of 31 December 2020) |
|
---|---|
|
|
Americas | 54.9 |
Europe | 26.8 |
Emerging Markets | 10.8 |
Pacific Basin | 7.4 |
Total | 100.0% |
Top 10 Countries (% of total portfolio equities as of 31 December 2020) |
|
---|---|
United States | 53.8 |
China | 7.2 |
Germany | 6.7 |
Japan | 5.4 |
Switzerland | 5.3 |
United Kingdom | 3.8 |
Belgium | 2.4 |
Sweden | 2.1 |
Denmark | 2.1 |
Hong Kong | 2.0 |
Sector Diversification (% of total portfolio equities as of 31 December 2020) |
|
---|---|
Communication Services | 8.0 |
Consumer Discretionary | 7.2 |
Consumer Staples | 2.4 |
Energy | 1.0 |
Financials | 5.1 |
Health Care | 27.9 |
Industrials | 19.6 |
Information Technology | 23.3 |
Materials | 4.3 |
Real Estate | — |
Utilities | 1.0 |
Total | 100.0% |